• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导致流感疫苗接种未达最佳效果的因素:一项针对心血管疾病患者的全国性电话调查结果

Factors contributing to suboptimal vaccination against influenza: results of a nationwide telephone survey of persons with cardiovascular disease.

作者信息

Madjid Mohammad, Alfred Anushayanthan, Sahai Achal, Conyers Jodie L, Casscells S Ward

机构信息

Atherosclerosis Research Laboratory, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas 77030, USA.

出版信息

Tex Heart Inst J. 2009;36(6):546-52.

PMID:20069079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2801927/
Abstract

Vaccination against influenza averts cardiovascular events and is recommended for all patients with coronary heart disease. Because data were unavailable regarding vaccination rates among such patients' household contacts, we sought to estimate the rate of influenza vaccination in persons with cardiovascular disease and their contacts. In 2004, we conducted a random, nationwide telephone survey of 1,202 adults (age, > or = 18 yr) to ascertain knowledge, attitudes, and behaviors regarding influenza vaccination. Of the interviewees, 134 (11.1%) had histories of heart disease or stroke. Of these 134, 57% were men, and 45% were > or = 65 years of age. Overall, 57% were inoculated against influenza in 2003-2004, and 68% intended the same during 2004-2005. Vaccination rates increased with age: 48% (ages, 18-49 yr), 68% (ages, 50-64 yr), and 75% (age, > or = 65 yr). Forty of 69 respondents (58%) reported that their spouses were vaccinated, and 7 of 21 (33%) reported the inoculation of children < or = 17 years old in their household. Only 65% of the 134 patients considered themselves to be of high-risk status. Chief reasons for remaining unvaccinated were disbelief in being at risk and fear of contracting influenza from the vaccine. Although seasonal influenza vaccination is recommended for all coronary heart disease patients and their household contacts, the practice is less prevalent than is optimal. Intensified approaches are needed to increase vaccination rates. These findings suggest a need to increase vaccination efforts in high-risk subjects, particularly amidst the emerging H1N1 pandemic.

摘要

接种流感疫苗可预防心血管事件,建议所有冠心病患者接种。由于缺乏此类患者家庭接触者的疫苗接种率数据,我们试图估算心血管疾病患者及其接触者的流感疫苗接种率。2004年,我们在全国范围内对1202名成年人(年龄≥18岁)进行了随机电话调查,以确定他们对流感疫苗接种的知识、态度和行为。受访者中,134人(11.1%)有心脏病或中风病史。在这134人中,57%为男性,45%年龄≥65岁。总体而言,2003 - 2004年期间57%的人接种了流感疫苗,2004 - 2005年期间68%的人打算接种。接种率随年龄增长而升高:18 - 49岁年龄组为48%,50 - 64岁年龄组为68%,≥65岁年龄组为75%。69名受访者中有40人(58%)报告其配偶接种了疫苗,21名受访者中有7人(33%)报告其家中17岁及以下的孩子接种了疫苗。134名患者中只有65%认为自己属于高危人群。未接种疫苗的主要原因是不相信自己有风险以及担心从疫苗中感染流感。尽管建议所有冠心病患者及其家庭接触者接种季节性流感疫苗,但实际接种情况不如理想。需要加强措施以提高接种率。这些发现表明有必要在高危人群中加大疫苗接种力度,尤其是在新出现的甲型H1N1流感大流行期间。

相似文献

1
Factors contributing to suboptimal vaccination against influenza: results of a nationwide telephone survey of persons with cardiovascular disease.导致流感疫苗接种未达最佳效果的因素:一项针对心血管疾病患者的全国性电话调查结果
Tex Heart Inst J. 2009;36(6):546-52.
2
Risk perception and information-seeking behaviour during the 2009/10 influenza A(H1N1)pdm09 pandemic in Germany.2009/10 年德国甲型 H1N1pdm09 流感大流行期间的风险感知和信息寻求行为。
Euro Surveill. 2012 Mar 29;17(13):20131.
3
[Pandemic influenza A (H1N1)v vaccination status and factors affecting vaccination: Ankara and Diyarbakır 2009 data from Turkey].[甲型H1N1流感大流行疫苗接种状况及影响接种的因素:2009年来自土耳其安卡拉和迪亚巴克尔的数据]
Mikrobiyol Bul. 2011 Oct;45(4):684-96.
4
Use of the Community Assessment for Public Health Response (CASPER) method to assess influenza vaccination and activity in Brazos County, Texas.利用社区公共卫生应对评估(CASPER)方法评估德克萨斯州布拉索斯县的流感疫苗接种和活动情况。
Vaccine. 2018 Sep 25;36(40):6001-6006. doi: 10.1016/j.vaccine.2018.08.030. Epub 2018 Aug 24.
5
Telephone survey assessment of household patterns of influenza vaccination, Twin Cities seven county metro area, 2008-2009.2008-2009 年,明尼苏达州双子城七县都会区家庭流感疫苗接种模式的电话调查评估。
Vaccine. 2011 May 23;29(23):4033-42. doi: 10.1016/j.vaccine.2011.03.045. Epub 2011 Mar 29.
6
Knowledge, attitudes and practices (KAP) related to the pandemic (H1N1) 2009 among Chinese general population: a telephone survey.中国一般人群对 2009 年大流行(H1N1)的知识、态度和实践(KAP):电话调查。
BMC Infect Dis. 2011 May 16;11:128. doi: 10.1186/1471-2334-11-128.
7
Monitoring pandemic influenza A(H1N1) vaccination coverage in Germany 2009/10 - results from thirteen consecutive cross-sectional surveys.监测德国 2009/10 年大流行性流感 A(H1N1)疫苗接种覆盖率 - 连续十三个横断面调查结果。
Vaccine. 2011 May 23;29(23):4008-12. doi: 10.1016/j.vaccine.2011.03.069. Epub 2011 Apr 2.
8
Factors in vaccination intention against the pandemic influenza A/H1N1.接种大流行流感 A/H1N1 疫苗的意愿因素。
Eur J Public Health. 2010 Oct;20(5):490-4. doi: 10.1093/eurpub/ckq054. Epub 2010 May 5.
9
Involvement of endocrinologists in the 2009 to 2010 H1N1 vaccination effort.内分泌学家参与 2009 年至 2010 年 H1N1 疫苗接种工作。
Endocr Pract. 2012 Jul-Aug;18(4):464-71. doi: 10.4158/EP11358.OR.
10
Influenza vaccination and intention to receive the pandemic H1N1 influenza vaccine among healthcare workers of British Columbia, Canada: a cross-sectional study.加拿大不列颠哥伦比亚省医护人员的流感疫苗接种和接种大流行性 H1N1 流感疫苗的意愿:一项横断面研究。
Infect Control Hosp Epidemiol. 2010 Oct;31(10):1017-24. doi: 10.1086/655465.

引用本文的文献

1
Electronic Nudges and Influenza Vaccination Among Patients With a History of Myocardial Infarction: Insights From 3 Nationwide Randomized Clinical Trials.心肌梗死病史患者中的电子助推与流感疫苗接种:来自3项全国性随机临床试验的见解
JAMA Cardiol. 2025 Jan 1;10(1):78-86. doi: 10.1001/jamacardio.2024.4648.
2
The trends and determinants of seasonal influenza vaccination after cardiovascular events in Canada: a repeated, pan-Canadian, cross-sectional study.加拿大心血管事件后季节性流感疫苗接种的趋势和决定因素:一项重复的、全加的、横断面研究。
Health Promot Chronic Dis Prev Can. 2023 Feb;43(2):87-97. doi: 10.24095/hpcdp.43.2.04.
3
Protective effect of influenza vaccination on cardiovascular diseases: a systematic review and meta-analysis.流感疫苗对心血管疾病的保护作用:系统评价和荟萃分析。
Sci Rep. 2020 Nov 26;10(1):20656. doi: 10.1038/s41598-020-77679-7.
4
Influenza Vaccination to Reduce Cardiovascular Morbidity and Mortality in Patients With COVID-19: JACC State-of-the-Art Review.COVID-19 患者中流感疫苗接种以降低心血管发病率和死亡率:JACC 现状述评。
J Am Coll Cardiol. 2020 Oct 13;76(15):1777-1794. doi: 10.1016/j.jacc.2020.08.028.
5
Flu vaccination among older persons: study of knowledge and practices.老年人流感疫苗接种:知识与实践研究
J Health Popul Nutr. 2019 Jan 3;38(1):2. doi: 10.1186/s41043-018-0159-8.
6
A Blueprint for Improving the Promotion and Delivery of Adult Vaccination in the United States.美国成人疫苗推广与接种改善蓝图
Rand Health Q. 2012 Mar 1;2(1):15. eCollection 2012 Spring.
7
Influenza vaccine as a coronary intervention for prevention of myocardial infarction.流感疫苗作为预防心肌梗死的冠状动脉干预措施。
Heart. 2016 Dec 15;102(24):1953-1956. doi: 10.1136/heartjnl-2016-309983. Epub 2016 Sep 29.
8
The challenge of vaccinating adults: attitudes and beliefs of the Canadian public and healthcare providers.成人疫苗接种面临的挑战:加拿大公众和医疗服务提供者的态度与信念。
BMJ Open. 2015 Sep 29;5(9):e009062. doi: 10.1136/bmjopen-2015-009062.
9
Acute myocardial infarction and influenza: a meta-analysis of case-control studies.急性心肌梗死与流感:病例对照研究的荟萃分析
Heart. 2015 Nov;101(21):1738-47. doi: 10.1136/heartjnl-2015-307691. Epub 2015 Aug 26.
10
Safety and tolerability of intradermal influenza vaccination in patients with cardiovascular disease.心血管疾病患者皮内流感疫苗接种的安全性和耐受性。
J Geriatr Cardiol. 2014 Jun;11(2):131-5. doi: 10.3969/j.issn.1671-5411.2014.02.007.

本文引用的文献

1
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.《2009年心脏病和中风统计数据更新:美国心脏协会统计委员会及中风统计小组委员会报告》
Circulation. 2009 Jan 27;119(3):e21-181. doi: 10.1161/CIRCULATIONAHA.108.191261. Epub 2008 Dec 15.
2
Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study.冠心病二级预防中流感疫苗接种预防冠状动脉缺血事件:FLUCAD研究
Eur Heart J. 2008 Jun;29(11):1350-8. doi: 10.1093/eurheartj/ehm581. Epub 2008 Jan 10.
3
Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects.流感流行和急性呼吸道疾病活动与尸检确诊的冠心病死亡激增有关:34892名受试者8年尸检结果
Eur Heart J. 2007 May;28(10):1205-10. doi: 10.1093/eurheartj/ehm035. Epub 2007 Apr 17.
4
Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology.流感疫苗接种作为心血管疾病的二级预防:美国心脏协会/美国心脏病学会的科学咨询意见
Circulation. 2006 Oct 3;114(14):1549-53. doi: 10.1161/CIRCULATIONAHA.106.178242. Epub 2006 Sep 18.
5
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.美国心脏协会/美国心脏病学会关于冠心病和其他动脉粥样硬化性血管疾病患者二级预防的指南:2006年更新版:得到美国国立心肺血液研究所认可。
Circulation. 2006 May 16;113(19):2363-72. doi: 10.1161/CIRCULATIONAHA.106.174516.
6
Influenza vaccination levels among persons aged > or =65 years and among persons aged 18-64 years with high-risk conditions--United States, 2003.2003年美国65岁及以上人群以及有高危状况的18 - 64岁人群的流感疫苗接种率
MMWR Morb Mortal Wkly Rep. 2005 Oct 21;54(41):1045-9.
7
Update: influenza vaccine supply and recommendations for prioritization during the 2005-06 influenza season.更新:2005 - 2006年流感季节流感疫苗供应及优先接种建议
MMWR Morb Mortal Wkly Rep. 2005 Sep 2;54(34):850.
8
Influenza vaccination is associated with a reduced risk of stroke.接种流感疫苗与降低中风风险相关。
Stroke. 2005 Jul;36(7):1501-6. doi: 10.1161/01.STR.0000170674.45136.80. Epub 2005 Jun 9.
9
Examining the coverage of influenza vaccination among people with cardiovascular disease in the United States.调查美国心血管疾病患者的流感疫苗接种覆盖率。
Am Heart J. 2005 Feb;149(2):254-9. doi: 10.1016/j.ahj.2004.07.028.
10
Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children.通过在儿童中使用三价减毒活流感疫苗(CAIV-T)实现成人对流感相关疾病的群体免疫。
Vaccine. 2005 Feb 18;23(13):1540-8. doi: 10.1016/j.vaccine.2004.09.025.